Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.

MLA

Jiménez-Gómez, Miguel, et al. “Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.” Archivos de Bronconeumologia, vol. 59, no. 8, Aug. 2023, pp. 512–13. EBSCOhost, https://doi.org/10.1016/j.arbres.2023.04.002.

APA

Jiménez-Gómez, M., Díaz Campos, R. M., & Diab Cáceres, L. (2023). Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma. Archivos de Bronconeumologia, 59(8), 512–513. https://doi.org/10.1016/j.arbres.2023.04.002

Chicago

Jiménez-Gómez, Miguel, Rocío Magdalena Díaz Campos, and Layla Diab Cáceres. 2023. “Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.” Archivos de Bronconeumologia 59 (8): 512–13. doi:10.1016/j.arbres.2023.04.002.